Kynurenic acid

CAS No. 492-27-3

Kynurenic acid ( Kynurenic acid; Kynurenic acid; Kynuronic acid )

Catalog No. M18648 CAS No. 492-27-3

Kynurenic acid, a natural metabolite of tryptophan via the kynurenine pathway, is a broad-spectrum excitatory amino acid antagonist.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Kynurenic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Kynurenic acid, a natural metabolite of tryptophan via the kynurenine pathway, is a broad-spectrum excitatory amino acid antagonist.
  • Description
    Kynurenic acid is a broad-spectrum amino acid antagonist used in research purposes. In particular it is a endogenous glutamate receptor antagonists, and exerts inhibitory action on the α7-nicotinic acetylcholine receptors.
  • Synonyms
    Kynurenic acid; Kynurenic acid; Kynuronic acid
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    α7 nicotinic acetylcholine receptor ;glutamate receptors
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    492-27-3
  • Formula Weight
    189.17
  • Molecular Formula
    C10H7NO3
  • Purity
    98%
  • Solubility
    DMSO : 9 mg/mL 47.58 mM;
  • SMILES
    C1=CC=C2C(=C1)C(=O)C=C(N2)C(=O)O
  • Chemical Name
    2-Quinolinecarboxylic acid, 4-hydroxy-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 3-Methoxytyramine

    3-Methoxytyramine a well known extracellular metabolite of 3-hydroxytyramine/dopamine is a neuromodulator.

  • Sulfo-SANPAH Crossli...

    Sulfo-SANPAH Crosslinker is a water-soluble isobisfunctional protein crosslinker.

  • Uprosertib

    Uprosertib (GSK2141795) is a selective, ATP-competitive, and orally bioavailable Akt inhibitor with IC50 of 180 nM, 328 nM, and 38 nM for Akt 1, 2 and 3, respectively. Phase 2.